Sutimlimab is a pioneering inhibitor of complement protein component 1, subcomponent s (C1s), representing the first in its class. This therapeutic targets C1s, a serine protease essential for the cleavage of complement components C4 and C2, which are critical in the formation of C3 convertase. Sutimlimab is primarily utilized in research focused on cold agglutinin disease, providing significant insights into the pathophysiological mechanisms and potential therapeutic interventions for this condition.
Sutimlimab is a pioneering inhibitor of complement protein component 1, subcomponent s (C1s), representing the first in its class. This therapeutic targets C1s, a serine protease essential for the cleavage of complement components C4 and C2, which are critical in the formation of C3 convertase. Sutimlimab is primarily utilized in research focused on cold agglutinin disease, providing significant insights into the pathophysiological mechanisms and potential therapeutic interventions for this condition.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
